Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Aug. 9, 2022
Individuals
with
South
Asian
ancestry
have
a
higher
risk
of
heart
disease
than
other
groups
but
been
largely
excluded
from
genetic
research.
Using
data
22,000
British
Pakistani
and
Bangladeshi
individuals
linked
electronic
health
records
the
Genes
&
Health
cohort,
we
conducted
genome-wide
association
studies
coronary
artery
its
key
factors.
power-adjusted
transferability
ratios,
found
evidence
for
majority
cardiometabolic
loci
powered
to
replicate.
The
performance
polygenic
scores
was
high
lipids
blood
pressure,
lower
BMI
disease.
Adding
score
clinical
factors
showed
significant
improvement
in
reclassification.
In
Mendelian
randomisation
using
transferable
as
instruments,
our
findings
were
consistent
results
European-ancestry
individuals.
Taken
together,
trait-specific
trait
between
populations
is
an
important
consideration
implications
prediction
causal
inference.
Nature Medicine,
Journal Year:
2023,
Volume and Issue:
29(7), P. 1793 - 1803
Published: July 1, 2023
Abstract
Identification
of
individuals
at
highest
risk
coronary
artery
disease
(CAD)—ideally
before
onset—remains
an
important
public
health
need.
Prior
studies
have
developed
genome-wide
polygenic
scores
to
enable
stratification,
reflecting
the
substantial
inherited
component
CAD
risk.
Here
we
develop
a
new
and
significantly
improved
score
for
CAD,
termed
GPS
Mult
,
that
incorporates
association
data
across
five
ancestries
(>269,000
cases
>1,178,000
controls)
ten
factors.
strongly
associated
with
prevalent
(odds
ratio
per
standard
deviation
2.14,
95%
confidence
interval
2.10–2.19,
P
<
0.001)
in
UK
Biobank
participants
European
ancestry,
identifying
20.0%
population
3-fold
increased
conversely
13.9%
decreased
as
compared
those
middle
quintile.
was
also
incident
events
(hazard
1.73,
1.70–1.76,
0.001),
3%
healthy
future
equivalent
existing
improving
discrimination
reclassification.
Across
multiethnic,
external
validation
datasets
inclusive
33,096,
124,467,
16,433
16,874
African,
European,
Hispanic
South
Asian
respectively,
demonstrated
strength
associations
all
outperformed
available
previously
published
scores.
These
contribute
field
provide
generalizable
framework
how
large-scale
integration
genetic
related
traits
from
diverse
populations
can
meaningfully
improve
prediction.
Genome Medicine,
Journal Year:
2022,
Volume and Issue:
14(1)
Published: June 28, 2022
Abstract
Background
Type
2
diabetes
(T2D)
is
a
worldwide
scourge
caused
by
both
genetic
and
environmental
risk
factors
that
disproportionately
afflicts
communities
of
color.
Leveraging
existing
large-scale
genome-wide
association
studies
(GWAS),
polygenic
scores
(PRS)
have
shown
promise
to
complement
established
clinical
intervention
paradigms,
improve
early
diagnosis
prevention
T2D.
However,
date,
T2D
PRS
been
most
widely
developed
validated
in
individuals
European
descent.
Comprehensive
assessment
non-European
populations
critical
for
equitable
deployment
practice
benefits
global
populations.
Methods
We
integrated
GWAS
European,
African,
East
Asian
construct
trans-ancestry
using
newly
Bayesian
modeling
method,
assessed
the
prediction
accuracy
multi-ethnic
Electronic
Medical
Records
Genomics
(eMERGE)
study
(11,945
cases;
57,694
controls),
four
Black
cohorts
(5137
9657
Taiwan
Biobank
(4570
84,996
controls).
additionally
evaluated
post
hoc
ancestry
adjustment
method
can
express
on
same
scale
across
ancestrally
diverse
facilitate
implementation
prospective
cohorts.
Results
The
was
significantly
associated
with
status
ancestral
groups
examined.
top
2%
distribution
identify
an
approximately
2.5–4.5-fold
increase
risk,
which
corresponds
increased
first-degree
relatives.
eliminated
major
distributional
differences
ancestries
without
compromising
its
predictive
performance.
Conclusions
By
integrating
from
multiple
populations,
we
PRS,
demonstrated
potential
as
meaningful
index
among
patients
settings.
Our
efforts
represent
first
step
towards
into
routine
healthcare.
Annual Review of Biomedical Data Science,
Journal Year:
2022,
Volume and Issue:
5(1), P. 293 - 320
Published: May 16, 2022
Polygenic
risk
scores
(PRS)
estimate
an
individual's
genetic
likelihood
of
complex
traits
and
diseases
by
aggregating
information
across
multiple
variants
identified
from
genome-wide
association
studies.
PRS
can
predict
a
broad
spectrum
have
therefore
been
widely
used
in
research
settings.
Some
work
has
investigated
their
potential
applications
as
biomarkers
preventative
medicine,
but
significant
is
still
needed
to
definitively
establish
communicate
absolute
patients
for
modifiable
factors
demographic
groups.
However,
the
biggest
limitation
currently
that
they
show
poor
generalizability
diverse
ancestries
cohorts.
Major
efforts
are
underway
through
methodological
development
data
generation
initiatives
improve
generalizability.
This
review
aims
comprehensively
discuss
current
progress
on
PRS,
affect
generalizability,
promising
areas
improving
accuracy,
portability,
implementation.
Cell Genomics,
Journal Year:
2022,
Volume and Issue:
2(8), P. 100155 - 100155
Published: July 26, 2022
How
race,
ethnicity,
and
ancestry
are
used
in
genomic
research
has
wide-ranging
implications
for
how
is
translated
into
clinical
care
incorporated
public
understanding.
Correlation
between
race
genetic
contributes
to
unresolved
complexity
the
scientific
community,
as
illustrated
by
heterogeneous
definitions
applications
of
these
variables.
Here,
we
offer
commentary
recommendations
on
use
across
arc
research,
including
data
harmonization,
analysis,
reporting.
While
informed
our
experiences
researchers
affiliated
with
NHLBI
Trans-Omics
Precision
Medicine
(TOPMed)
program,
applicable
basic
translational
diverse
populations
genome-wide
data.
Moving
forward,
considerable
collaborative
effort
will
be
required
ensure
that
described
appropriately
generate
knowledge
yields
broad
equitable
benefit.
Science,
Journal Year:
2023,
Volume and Issue:
380(6643)
Published: April 27, 2023
Thousands
of
genomic
regions
have
been
associated
with
heritable
human
diseases,
but
attempts
to
elucidate
biological
mechanisms
are
impeded
by
an
inability
discern
which
positions
functionally
important.
Evolutionary
constraint
is
a
powerful
predictor
function,
agnostic
cell
type
or
disease
mechanism.
Single-base
phyloP
scores
from
240
mammals
identified
3.3%
the
genome
as
significantly
constrained
and
likely
functional.
We
compared
annotation,
association
studies,
copy-number
variation,
clinical
genetics
findings,
cancer
data.
Constrained
enriched
for
variants
that
explain
common
heritability
more
than
other
functional
annotations.
Our
results
improve
variant
annotation
also
highlight
regulatory
landscape
still
needs
be
further
explored
linked
disease.
Cell Genomics,
Journal Year:
2023,
Volume and Issue:
3(1), P. 100241 - 100241
Published: Jan. 1, 2023
Polygenic
risk
scores
(PRSs)
have
been
widely
explored
in
precision
medicine.
However,
few
studies
thoroughly
investigated
their
best
practices
global
populations
across
different
diseases.
We
here
utilized
data
from
Global
Biobank
Meta-analysis
Initiative
(GBMI)
to
explore
methodological
considerations
and
PRS
performance
9
biobanks
for
14
disease
endpoints.
Specifically,
we
constructed
PRSs
using
pruning
thresholding
(P
+
T)
PRS-continuous
shrinkage
(CS).
For
both
methods,
a
European-based
linkage
disequilibrium
(LD)
reference
panel
resulted
comparable
or
higher
prediction
accuracy
compared
with
several
other
non-European-based
panels.
PRS-CS
overall
outperformed
the
classic
P
T
method,
especially
endpoints
SNP-based
heritability.
Notably,
is
heterogeneous
endpoints,
biobanks,
ancestries,
asthma,
which
has
known
variation
prevalence
populations.
Overall,
provide
lessons
construction,
evaluation,
interpretation
GBMI
resources
highlight
importance
of
biobank-scale
genomics
era.
Physiological Reviews,
Journal Year:
2023,
Volume and Issue:
103(3), P. 2039 - 2055
Published: Jan. 12, 2023
Genome-wide
association
studies
(GWAS)
aim
to
identify
common
genetic
variants
that
are
associated
with
traits
and
diseases.
Since
2005,
more
than
5,000
GWAS
have
been
published
for
almost
as
many
traits.
These
offered
insights
into
the
loci
genes
underlying
phenotypic
traits,
highlighted
correlations
across
diseases,
beginning
demonstrate
clinical
utility
by
identifying
individuals
at
increased
risk
widely
utilized
cardiovascular
diseases
facilitated
multicenter
registry
large
biobank
data
sets.
In
this
review,
we
describe
how
informed
architecture
of
they
provided
disease
pathophysiology,
using
archetypal
conditions
both
rare
We
also
sets
can
complement
disease-specific
studies,
particularly
rarer
findings
from
potential
impact
on
care.
Finally,
discuss
outstanding
challenges
facing
research
in
field
be
addressed.